Jonathan Seaton

Illumina has appointed Jonathan Seaton as senior VP for corporate and business development. In this role, Seaton will be responsible for global business development activities, including strategic commercial deals, mergers and acquisitions, licensing, and partnerships. He joins Illumina from Becton Dickinson, where he was VP and head of strategy and business development for the Life Sciences segment. He previously held leadership roles at Hoffman-La Roche, Roche Tissue Diagnostics, LS9, and several consulting firms and investment banks.

To read the full story....

Register for Free.

...and receive Daily News bulletins.

Already have an account?
Login Now.

The UK's Human Fertility and Embryology Authority calls for consumer genetic testing companies to warn customers that testing could uncover family secrets, according to the Guardian.

The New York Times reports that United Nations delegates have been discussing how to govern the genetic resources of the deep sea.

Researchers have transplanted edited cells into mice that appear to combat cocaine addiction, New Scientist reports.

In PNAS this week: analysis of proteolytic enzymes secreted by circulating tumor cells, phylogenetic study of Fv1 evolution, and more.